Enter assignee name

Forward Citations = 139

Loading Chart...

4 inventors (with patents filed for the assignee):

Shailendra K Saxena (12 out of 15 patents)

Wojciech J Ardelt (7 out of 12 patents)

Stanislaw M Mikulski (5 out of 5 patents)

4. Kuslima Shogen (1 out of 1 patent)

20 patents: Sort by Forward Citations

1. 7763449 - Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an N-terminal leader sequence that is at least one residue long (2010-07-27),

2. 7585655 - Nucleic acid encoding a fusion protein incorporating a cysteinized ribonuclease (2009-09-08),

3. 7585654 - Nucleic acid encoding cysteinized ribonuclease to which a targeting moiety can be conjugated (2009-09-08),

4. 7556953 - Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an N-terminal leader sequence (2009-07-07),

5. 7556952 - Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of a known amino acid sequence and an initial N-terminal residue (2009-07-07),

6. 7556951 - Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an n-terminal leader sequence that is at least one residue long (2009-07-07),

7. 7473542 - Cysteinized ribonuclease and targeting moiety conjugated thereto (2009-01-06),

8. 7442536 - Cysteinized ribonuclease and targeting moiety conjugated thereto (2008-10-28),

9. 7442535 - Fusion protein incorporating a cysteinized ribonuclease (2008-10-28),

10. 7229824 - Ribonucleases and methods of making them recombinantly (2007-06-12),

11. 6423515 - Methods of making nucleic acids encoding ribonucleases (2002-07-23),

12. 6290951 - Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells (2001-09-18),

13. 6239257 - Family of proteins belonging to the pancreatic ribonuclease a superfamily (2001-05-29),

14. 6175003 - Nucleic acids encoding ribonucleases and methods of making them (2001-01-16),

15. 5728805 - Pharmaceuticals and method for making them (1998-03-17),

Alfacell Corporation is a biopharmaceutical company focused on the development of novel nucleic acid-based therapeutics for the treatment of cancer. Our lead product candidate is in Phase 3 clinical trials for the treatment of acute myeloid leukemia. We are dedicated to advancing innovative therapies that have the potential to improve outcomes for patients with serious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

20 Patents

#11 in Somerset, NJ

#623 in New Jersey

#15,856 in US

#30,316 in the World

Somerset, NJ, United States of America

Alfacell Corporation

Forward Citations = 139

4 inventors:

Shailendra K Saxena (12 out of 15 patents)

Wojciech J Ardelt (7 out of 12 patents)

Stanislaw M Mikulski (5 out of 5 patents)

4. Kuslima Shogen (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com